Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade
Clinical trial NCT00945477 · TERMINATED
Trial details
- NCT number
- NCT00945477
- Sponsor
- Illinois CancerCare, P.C.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-10-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.